Related content

Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms

By Gunes Arzu   Dahl Marja-Liisa  

Pharmacogenomics, Vol. 9, Iss. 5, 2008-05 ,pp. : 625-637

Future Medicine

Access to resources Recommend Favorite

Genetic Polymorphism in CYP2E1: Population Distribution of CYP2E1 Activity

By Neafsey Pat  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 12, Iss. 5-6, 2009-05 ,pp. : 362-388

Taylor & Francis Ltd

Access to resources Recommend Favorite

Genetic polymorphisms of CYP1A1 in a Korean population

By Park Duk  

Archives of Toxicology, Vol. 78, Iss. 6, 2004-06 ,pp. : 306-308

Springer Publishing Company

Access to resources Recommend Favorite

Losartan hydroxylation phenotype in an Ecuadorian population: influence of CYP2C9 genetic polymorphism, habits and gender

By Dorado Pedro   Beltrán Leonardo J   Machín Esther   Peñas-LLedó Eva M   Terán Enrique   LLerena Adrián  

Pharmacogenomics, Vol. 13, Iss. 15, 2012-11 ,pp. : 1711-1717

Future Medicine

Access to resources Recommend Favorite

Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans

By Ghotbi Roza   Christensen Magnus   Roh Hyung-Keun   Ingelman-Sundberg Magnus   Aklillu Eleni   Bertilsson Leif  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 6, 2007-06 ,pp. : 537-546

Springer Publishing Company

Access to resources Recommend Favorite